Effects of incretins on blood pressure: A promising therapy for type 2 diabetes mellitus with hypertension

Glycosmedia, 2012

(2012), Effects of incretins on blood pressure: A promising therapy for type 2 diabetes mellitus with hypertension.
Tel:  023 6875 7882 Fax:  023 6875 7882 Email: Publication History Issue published online: 23 FEB 2012 Article first published online: 23 FEB 2012 Accepted manuscript online: 31 OCT 2011 11:35AM EST Received 5 September 2011; revised 1 October 2011; accepted 25 October 2011.
A recent epidemiological study reported that approximately 63% of T2DM patients also have high blood pressure (>130/80 mmHg), which doubles their risk of cardiac events.
Of the medications used to treat T2DM, the incretins are a group of peptides that not only regulate blood glucose effectively and moderately, but also protect patients against cardiovascular events and improve several cardiovascular parameters.
Here were review data from preclinical and short- and long-term clinical studies investigating the antihypertensive effects of incretins.
We conclude that incretins can lower blood pressure of T2DM patients, independent of weight loss, and will surely improve the prognosis of these patients.
More content like this Find more content: Find more content written by: Copyright © 1999–2012 John Wiley & Sons, Inc.